Protective effects of Bacillus subtilis fermentation extract against ochratoxin A-induced nephrotoxicity and immunotoxicity in broiler chickens
Authors:
Open Access
- 1 June 2022
- journal article
- research article
- Published by Walter de Gruyter GmbH in Journal of Veterinary Research
- Vol. 66 (2) , 167-177
Abstract
Introduction: Ochratoxin A (OTA) is a mycotoxin notably produced by Aspergillus and Penicillium spp. Bacillus subtilis fermentation extract (BSFE) contains specific enzymes which hydrolyse OTA. This study evaluated the efficiency of BSFE in ameliorating the immunotoxic and nephrotoxic effects of OTA in broiler chickens. Material and Methods: Day-old broiler chicks were divided equally into four groups of ten: control, OTA (0.5 mg/kg feed), BSFE product (1 mL/L water) and OTA + BSFE at the same concentrations. The chicks were vaccinated against avian influenza, Newcastle disease, and infectious bronchitis, and lymphoproliferation was induced in all birds by phytohaemagglutinin-P (PHA-P). Serum samples were taken before sacrifice and organ tissue samples were taken after, in which renal function biomarkers were assayed and the presence of OTA residue was evaluated by high-performance thin-layer chromatography. Protein markers of apoptosis were determined by qPCR, and tissue lesions were examined histopathologically. Results: Exposure to OTA significantly decreased the antibody response to the vaccines and the lymphoproliferative response to PHA-P, and significantly elevated the renal function indicators: serum urea, uric acid and creatinine. It also induced oxidative stress (reduced catalase activity and glutathione concentration), lipid peroxidation (increased malondialdehyde content), apoptosis (increased Bax and Caspase-3 and decreased Bcl-2 gene levels) and pathological lesions in kidney, bursa of Fabricius, spleen and thymus tissue. Residues of OTA were detected in the serum and tissue. BSFE mitigated most of these toxic effects. Conclusion: BSFE counters OTA-induced immunotoxicity and nephrotoxicity because of its content of carboxypeptidase and protease enzymes.Keywords
This publication has 31 references indexed in Scilit:
- Ochratoxin A induces oxidative DNA damage and G1 phase arrest in human peripheral blood mononuclear cells in vitroToxicology Letters, 2012
- Impact of mycotoxins on humans and animalsJournal of Saudi Chemical Society, 2011
- Isolation of Bacillus spp. from Thai fermented soybean (Thua-nao): screening for aflatoxin B1and ochratoxin A detoxificationJournal of Applied Microbiology, 2008
- Ochratoxin A: An overview on toxicity and carcinogenicity in animals and humansMolecular Nutrition & Food Research, 2007
- Ochratoxin A: An overview on toxicity and carcinogenicity in animals and humansMolecular Nutrition & Food Research, 2006
- Experimental ochratoxicosis in broiler chickensAvian Pathology, 2006
- Dry Bean Protein FunctionalityCritical Reviews in Biotechnology, 2002
- Effects of cyclosporin A on the development of immune-mediated interstitial nephritisKidney International, 1988
- A standard haemagglutination inhibition test for Newcastle disease. (2) Vaccination and challengeVeterinary Record, 1974
- Ochratoxin A, a Toxic Metabolite produced by Aspergillus ochraceus Wilh.Nature, 1965